AUTOIMMUNE HEMOLYTIC ANEMIA
Clinical trials for AUTOIMMUNE HEMOLYTIC ANEMIA explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE HEMOLYTIC ANEMIA trials appear
Sign up with your email to follow new studies for AUTOIMMUNE HEMOLYTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cell therapy tested for Tough-to-Treat blood disorder
Disease control CompletedThis early-stage study tested the safety and initial effectiveness of a new cell therapy called YTS109 for people with severe autoimmune hemolytic anemia (AIHA) who haven't responded to at least three previous treatments. The trial involved just 7 participants and focused on find…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA
Phase: PHASE1 • Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Scientists probe immune System's role in rare blood disorder
Knowledge-focused CompletedThis study aimed to better understand autoimmune hemolytic anemia (AIHA), a condition where the immune system attacks a person's own red blood cells. Researchers compared the types and behaviors of specific immune cells (T cells) in 27 patients with AIHA to those in healthy volun…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC
-
Doctors track rare blood disorders to find better treatment paths
Knowledge-focused CompletedThis study created a registry to track children and young adults with severe immune cytopenias—rare conditions where the immune system attacks blood cells. Researchers observed 80 participants over four years to better understand these diseases, improve diagnosis, and document ho…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA
Sponsor: Medical University of Graz • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC